KSA companion animal osteoarthritis market report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

The Saudi Arabia Companion Animal Osteoarthritis Market, valued at USD 35 million, is growing due to increased pet ownership and innovative treatments like NSAIDs and regenerative medicine.

Region:Saudi Arabia

Author(s):Geetanshi

Product Code:KRAC2391

Pages:83

Published On:October 2025

Join Meeting Now

Your data is secure and never shared.

About the Report

Base Year 2024

Listen to the audio summary

Saudi Arabia Companion Animal Osteoarthritis Market Overview

  • The Saudi Arabia Companion Animal Osteoarthritis Market is valued at USD 35 million, based on a five-year historical analysis and proportional sizing from the broader animal health and veterinary medicine markets. This growth is primarily driven by increasing pet ownership rates, a rising focus on pet health, and significant advancements in veterinary pharmaceuticals and clinical care. The demand for effective treatment options for osteoarthritis in companion animals has surged, supported by the expansion of veterinary clinics and the introduction of innovative therapies, creating a robust market environment .
  • Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their high population density and concentration of veterinary services. Urbanization in these areas has led to a greater number of pet owners seeking specialized care for their animals, thus driving the demand for osteoarthritis treatments .
  • The Saudi Arabian government regulates veterinary practice quality through the Executive Regulations of the Veterinary Medical Practice Law, issued by the Ministry of Environment, Water and Agriculture in 2023. These regulations require veterinarians to complete accredited continuing education—including modules on musculoskeletal disorders such as osteoarthritis—and mandate licensing for all veterinary practitioners and clinics. The law establishes compliance standards for veterinary care, ensuring that companion animals receive effective and up-to-date therapies .
Saudi Arabia Companion Animal Osteoarthritis Market Size

Saudi Arabia Companion Animal Osteoarthritis Market Segmentation

By Type:The market is segmented into various types of treatments for osteoarthritis in companion animals. The subsegments include Non-steroidal anti-inflammatory drugs (NSAIDs), Nutraceuticals and supplements, Disease-modifying osteoarthritis drugs (DMOADs), Surgical interventions, Physical therapy and rehabilitation, Regenerative medicine, and Others. Among these, NSAIDs are the most widely used due to their effectiveness in managing pain and inflammation in pets. The increasing prevalence of osteoarthritis in aging pets has led to a higher demand for these medications, making them a dominant force in the market .

Saudi Arabia Companion Animal Osteoarthritis Market segmentation by Type.

By End-User:The end-users of osteoarthritis treatments in companion animals include pet owners, veterinary clinics, animal hospitals, research institutions, and animal rehabilitation centers. Pet owners represent the largest segment as they are directly responsible for seeking treatment for their pets. The increasing awareness of pet health and the willingness to invest in their well-being have led to a significant rise in demand from this segment, making it a key driver of market growth .

Saudi Arabia Companion Animal Osteoarthritis Market segmentation by End-User.

Saudi Arabia Companion Animal Osteoarthritis Market Competitive Landscape

The Saudi Arabia Companion Animal Osteoarthritis Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Vetoquinol S.A., Ceva Santé Animale, Virbac S.A., IDEXX Laboratories, Inc., Vetanco S.A., Montajat Veterinary Pharmaceuticals Co., Ltd., Salehiya Healthcare, Alkhoraif Veterinary Company, MM Group (Avico agent), Pharma Care Leading Manufacturing Co., Ltd., VetIQ, Inc. contribute to innovation, geographic expansion, and service delivery in this space.

Zoetis Inc.

1952

Parsippany, New Jersey, USA

Merck Animal Health

1891

Rahway, New Jersey, USA

Elanco Animal Health

1954

Greenfield, Indiana, USA

Boehringer Ingelheim Animal Health

1885

Ingelheim am Rhein, Germany

Vetoquinol S.A.

1933

Lure, France

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate (Saudi Arabia animal health segment)

Market Penetration Rate (companion animal osteoarthritis products)

Product Portfolio Breadth (number of osteoarthritis SKUs/therapies)

Distribution Network Coverage (number of clinics/pharmacies served in KSA)

Local Partnerships/Presence (JV, distributor, or direct office in Saudi Arabia)

Saudi Arabia Companion Animal Osteoarthritis Market Industry Analysis

Growth Drivers

  • Increasing Pet Ownership:The pet ownership rate in Saudi Arabia has surged, with approximately 60% of households owning at least one pet as of in future. This translates to around 6 million pet owners, creating a substantial market for companion animal healthcare. The growing trend of pet humanization drives demand for advanced treatments, including osteoarthritis management, as owners seek to enhance their pets' quality of life. This trend is expected to continue, bolstered by cultural shifts towards pet companionship.
  • Rising Awareness of Pet Health:Awareness regarding pet health has significantly increased, with 70% of pet owners in Saudi Arabia now prioritizing veterinary care. This shift is supported by educational campaigns and social media, which emphasize the importance of regular check-ups and preventive care. As a result, the demand for osteoarthritis treatments is expected to rise, with an estimated 1.5 million pets suffering from this condition, highlighting the need for effective management solutions in the market.
  • Advancements in Veterinary Medicine:The veterinary sector in Saudi Arabia is witnessing rapid advancements, with over 200 veterinary clinics now offering specialized services. Innovations in treatment options, such as regenerative medicine and minimally invasive surgeries, are becoming more accessible. This progress is crucial for managing osteoarthritis in pets, as it allows for more effective and less invasive treatment methods, thereby increasing the overall market potential for companion animal healthcare solutions.

Market Challenges

  • High Treatment Costs:The cost of osteoarthritis treatments for pets can be prohibitively high, with average treatment expenses ranging from SAR 1,500 to SAR 5,000 per case. This financial burden can deter pet owners from seeking necessary care, particularly in lower-income households. As a result, many pets may go untreated, leading to worsening health conditions and ultimately impacting the overall market for companion animal healthcare in Saudi Arabia.
  • Limited Availability of Specialized Veterinary Services:Despite the growth in veterinary clinics, specialized services for osteoarthritis remain limited, particularly in rural areas. Only about 30% of clinics offer advanced treatments, which restricts access for many pet owners. This gap in service availability can hinder the effective management of osteoarthritis, leading to a significant portion of the pet population not receiving adequate care, thus affecting market growth potential.

Saudi Arabia Companion Animal Osteoarthritis Market Future Outlook

The future of the companion animal osteoarthritis market in Saudi Arabia appears promising, driven by increasing pet ownership and a growing emphasis on pet health. As more pet owners seek advanced treatment options, the market is likely to see innovations in veterinary care, including telemedicine and personalized treatment plans. Additionally, the integration of technology in pet care will enhance service delivery, making it easier for pet owners to access necessary treatments and improve their pets' quality of life.

Market Opportunities

  • Expansion of Veterinary Clinics:The ongoing expansion of veterinary clinics, particularly in underserved areas, presents a significant opportunity. With an estimated 15% increase in new clinics expected in future, this growth will enhance access to specialized osteoarthritis treatments, catering to the rising demand from pet owners seeking quality care for their pets.
  • Development of Innovative Treatment Options:There is a growing opportunity for the development of innovative treatment options, such as biologics and nutraceuticals. With the market for pet supplements projected to reach SAR 300 million in future, companies that invest in research and development of effective osteoarthritis treatments can capitalize on this trend, meeting the needs of health-conscious pet owners.

Scope of the Report

SegmentSub-Segments
By Type

Non-steroidal anti-inflammatory drugs (NSAIDs)

Nutraceuticals and supplements

Disease-modifying osteoarthritis drugs (DMOADs)

Surgical interventions (e.g., joint replacement, arthroscopy)

Physical therapy and rehabilitation

Regenerative medicine (stem cell therapy, PRP)

Others (adjunctive therapies, alternative medicine)

By End-User

Pet owners

Veterinary clinics

Animal hospitals

Research institutions

Animal rehabilitation centers

By Distribution Channel

Online retail

Veterinary clinics and hospitals

Pet specialty stores

Pharmacies

By Treatment Method

Medication

Surgery

Rehabilitation and physical therapy

Nutritional management

By Animal Type

Dogs

Cats

Others (rabbits, small mammals)

By Age Group

Young adults

Middle-aged

Senior

By Price Range

Low

Medium

High

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Environment, Water and Agriculture)

Veterinary Clinics and Animal Hospitals

Pharmaceutical Companies specializing in Animal Health

Pet Food Manufacturers

Pet Supply Retailers

Animal Welfare Organizations

Insurance Companies offering Pet Health Insurance

Players Mentioned in the Report:

Zoetis Inc.

Merck Animal Health

Elanco Animal Health

Boehringer Ingelheim Animal Health

Vetoquinol S.A.

Ceva Sante Animale

Virbac S.A.

IDEXX Laboratories, Inc.

Vetanco S.A.

Montajat Veterinary Pharmaceuticals Co., Ltd.

Salehiya Healthcare

Alkhoraif Veterinary Company

MM Group (Avico agent)

Pharma Care Leading Manufacturing Co., Ltd.

VetIQ, Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Saudi Arabia Companion Animal Osteoarthritis Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Saudi Arabia Companion Animal Osteoarthritis Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Saudi Arabia Companion Animal Osteoarthritis Market Analysis

3.1 Growth Drivers

3.1.1 Increasing pet ownership
3.1.2 Rising awareness of pet health
3.1.3 Advancements in veterinary medicine
3.1.4 Growth in disposable income

3.2 Market Challenges

3.2.1 High treatment costs
3.2.2 Limited availability of specialized veterinary services
3.2.3 Lack of awareness among pet owners
3.2.4 Regulatory hurdles

3.3 Market Opportunities

3.3.1 Expansion of veterinary clinics
3.3.2 Development of innovative treatment options
3.3.3 Increasing demand for pet insurance
3.3.4 Growth in e-commerce for pet products

3.4 Market Trends

3.4.1 Shift towards preventive care
3.4.2 Rise in organic and natural pet products
3.4.3 Integration of technology in pet care
3.4.4 Focus on holistic treatment approaches

3.5 Government Regulation

3.5.1 Veterinary practice regulations
3.5.2 Animal welfare laws
3.5.3 Import/export regulations for veterinary products
3.5.4 Licensing requirements for veterinary professionals

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Saudi Arabia Companion Animal Osteoarthritis Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Saudi Arabia Companion Animal Osteoarthritis Market Segmentation

8.1 By Type

8.1.1 Non-steroidal anti-inflammatory drugs (NSAIDs)
8.1.2 Nutraceuticals and supplements
8.1.3 Disease-modifying osteoarthritis drugs (DMOADs)
8.1.4 Surgical interventions (e.g., joint replacement, arthroscopy)
8.1.5 Physical therapy and rehabilitation
8.1.6 Regenerative medicine (stem cell therapy, PRP)
8.1.7 Others (adjunctive therapies, alternative medicine)

8.2 By End-User

8.2.1 Pet owners
8.2.2 Veterinary clinics
8.2.3 Animal hospitals
8.2.4 Research institutions
8.2.5 Animal rehabilitation centers

8.3 By Distribution Channel

8.3.1 Online retail
8.3.2 Veterinary clinics and hospitals
8.3.3 Pet specialty stores
8.3.4 Pharmacies

8.4 By Treatment Method

8.4.1 Medication
8.4.2 Surgery
8.4.3 Rehabilitation and physical therapy
8.4.4 Nutritional management

8.5 By Animal Type

8.5.1 Dogs
8.5.2 Cats
8.5.3 Others (rabbits, small mammals)

8.6 By Age Group

8.6.1 Young adults
8.6.2 Middle-aged
8.6.3 Senior

8.7 By Price Range

8.7.1 Low
8.7.2 Medium
8.7.3 High

9. Saudi Arabia Companion Animal Osteoarthritis Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate (Saudi Arabia animal health segment)
9.2.4 Market Penetration Rate (companion animal osteoarthritis products)
9.2.5 Product Portfolio Breadth (number of osteoarthritis SKUs/therapies)
9.2.6 Distribution Network Coverage (number of clinics/pharmacies served in KSA)
9.2.7 Local Partnerships/Presence (JV, distributor, or direct office in Saudi Arabia)
9.2.8 Regulatory Approvals (MOEWA/SFDA product registrations)
9.2.9 Customer Satisfaction Score (veterinarian/end-user feedback)
9.2.10 Pricing Competitiveness (relative to market average)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Zoetis Inc.
9.5.2 Merck Animal Health
9.5.3 Elanco Animal Health
9.5.4 Boehringer Ingelheim Animal Health
9.5.5 Vetoquinol S.A.
9.5.6 Ceva Santé Animale
9.5.7 Virbac S.A.
9.5.8 IDEXX Laboratories, Inc.
9.5.9 Vetanco S.A.
9.5.10 Montajat Veterinary Pharmaceuticals Co., Ltd.
9.5.11 Salehiya Healthcare
9.5.12 Alkhoraif Veterinary Company
9.5.13 MM Group (Avico agent)
9.5.14 Pharma Care Leading Manufacturing Co., Ltd.
9.5.15 VetIQ, Inc.

10. Saudi Arabia Companion Animal Osteoarthritis Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Environment, Water and Agriculture
10.1.2 Ministry of Health
10.1.3 Ministry of Commerce

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in veterinary infrastructure
10.2.2 Funding for animal health initiatives

10.3 Pain Point Analysis by End-User Category

10.3.1 Pet owners
10.3.2 Veterinary professionals

10.4 User Readiness for Adoption

10.4.1 Awareness of treatment options
10.4.2 Accessibility of veterinary services

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Long-term health benefits for pets
10.5.2 Cost savings through preventive care

11. Saudi Arabia Companion Animal Osteoarthritis Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market gaps identification

1.2 Business model development


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban retail vs rural NGO tie-ups


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands


5. Unmet Demand & Latent Needs

5.1 Category gaps

5.2 Consumer segments


6. Customer Relationship

6.1 Loyalty programs

6.2 After-sales service


7. Value Proposition

7.1 Sustainability

7.2 Integrated supply chains


8. Key Activities

8.1 Regulatory compliance

8.2 Branding

8.3 Distribution setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix
9.1.2 Pricing band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target countries
9.2.2 Compliance roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone tracking
15.2.2 Activity scheduling

Research Methodology

Phase 1: Approach1

Desk Research

  • Analysis of existing market reports and publications on companion animal osteoarthritis in Saudi Arabia
  • Review of veterinary journals and articles focusing on osteoarthritis treatments and prevalence in pets
  • Examination of government and industry statistics related to pet ownership and healthcare spending

Primary Research

  • Interviews with veterinarians specializing in orthopedics and pet care
  • Surveys conducted with pet owners to assess awareness and treatment options for osteoarthritis
  • Focus groups with pet care professionals to gather insights on market trends and product preferences

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including veterinary clinics and pet pharmacies
  • Triangulation of qualitative insights from interviews with quantitative data from surveys
  • Sanity checks through expert panel reviews comprising veterinarians and market analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the total market size based on national pet ownership statistics and prevalence rates of osteoarthritis
  • Segmentation of the market by treatment types, including pharmaceuticals, supplements, and therapies
  • Incorporation of trends in pet healthcare spending and consumer behavior towards pet wellness

Bottom-up Modeling

  • Collection of sales data from leading veterinary clinics and pet pharmacies
  • Estimation of average treatment costs and frequency of osteoarthritis-related veterinary visits
  • Volume x cost analysis to derive revenue projections for each treatment segment

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating factors such as pet population growth and increasing awareness of pet health
  • Scenario modeling based on potential changes in regulations and veterinary practices
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Veterinary Clinics60Veterinarians, Clinic Managers
Pet Owners120Dog and Cat Owners, Pet Care Enthusiasts
Pet Pharmacies50Pharmacy Managers, Veterinary Pharmacists
Pet Care Professionals40Pet Trainers, Groomers, and Behaviorists
Industry Experts40Market Analysts, Veterinary Researchers

Frequently Asked Questions

What is the current value of the Saudi Arabia Companion Animal Osteoarthritis Market?

The Saudi Arabia Companion Animal Osteoarthritis Market is valued at approximately USD 35 million, driven by increasing pet ownership, a focus on pet health, and advancements in veterinary pharmaceuticals and clinical care.

What factors are driving the growth of the Companion Animal Osteoarthritis Market in Saudi Arabia?

Which cities in Saudi Arabia are leading in the Companion Animal Osteoarthritis Market?

What regulations govern veterinary practices in Saudi Arabia?

Other Regional/Country Reports

Vietnam Companion Animal Osteoarthritis Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Indonesia Companion Animal Osteoarthritis Market

Malaysia Companion Animal Osteoarthritis Market

KSA Companion Animal Osteoarthritis Market

APAC Companion Animal Osteoarthritis Market

SEA Companion Animal Osteoarthritis Market

Other Adjacent Reports

Australia Veterinary Pharmaceuticals Market Size, Share & Forecast, By Product Type, Animal Type & Distribution Channel, 2025–2032

South Africa Animal Health Supplements Market

Indonesia Pet Nutrition Market

Indonesia Veterinary Diagnostics Market Size, Share & Forecast, By Product Type, Animal Type & End User, 2025–2032

Malaysia Animal Rehabilitation Services Market

Middle East Pet Insurance Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Belgium Veterinary Clinics Market

South Korea Animal Pain Management Market

Germany Regenerative Medicine for Animals Market

South Africa Companion Animal Wellness Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022
Saudi Pet Osteoarthritis Market | 2019 – 2030 | Ken Research